DCPN
CHANGE OF OWNER RECEIVED FROM IB
04/02/2026
Back to search
Official data from USPTO
BIOFRONTERA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
BIOFRONTERA
ST13
US500000079043058Class
1, 5, 35, 38, 42, 44
Filing
79043058
Registration
3508876
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
51
Latest update
04/04/2026
Classification
Registered
Trademark type
Word
Nice classes
1, 5, 35, 38, 42, 44
Filing date
03/09/2007
Registration date
09/30/2008
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/19/2018
Last transaction
04/04/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
US
Examiner
BROWN, TINA
Law office
L50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Biofrontera Inc.
Biofrontera AG
Biofrontera AG
Representatives
Chelsea VanderWoude Grossman Tucker Perreault & Pfleger PLLC
Technical classification
Nice Classes
Class 1Class 5Class 35Class 38Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in industry; industrial chemicals; biological preparationsother than for medical or veterinary purposesbiological tissuebloodstem cellsumbilical cords and placentas for scientific research usebiologically active enzymes and microorganisms for the manufacture of medicaments and pharmaceutical compositions; biochemical compounds and genetic preparations for production and researchincluding the manufacture of pharmaceuticalscatalysts for chemical and biochemical processesbiochemicals in the nature of precursors for in vitro genetic engineering usebiochemicals in the nature of polypeptides for in vitro research use; gene banks as included in this classbiotechnology formed genes for use in the production of medicaments and pharmaceutical compositions; crop protection agents as included in this classadjuvants for use in the manufacture of herbicideschemical preparations for the treatment of seeds
Class 5
Pharmaceutical and veterinary preparationspharmaceutical preparations in the nature of antidepressantspharmaceutical preparations for the treatment of migraine and cancerveterinary preparations for the treatment of cancer; sanitary preparations for medical purposes; preparations for destroying vermin; fungicidesherbicides; crop protection agents as included in this classacaricides for agricultural useagricultural biopesticidesagricultural pesticides; bouillons for bacteriological cultures for medical usepreparations for establishing an environment for the culture of bacteria and enzymes; bacteriological preparations for medical and veterinary use; biological preparations for medical purposes; biological preparations for veterinary purposes; biochemical preparations for medical and veterinary purposes; enzymes for medical purposes; enzymes for veterinary purposes; enzyme preparations for medical and veterinary purposes; ferments for pharmaceutical purposes; vaccines; articles for headacheheadache treatment preparations; nutritive substances for microorganisms for medical purposes; plasters for medical purposes; pharmaceutical preparations for the treatment of migraine and cancer; vesicants; diagnostic preparations for medical purposes; chemical preparations for pharmaceutical purposespharmaceutical preparations for use in chemotherapynucleic acid sequences and chemical reagents for medical purposes; chemical preparations for veterinary purposesnucleic acid sequences and chemical reagents for veterinary purposes; medicines for human purposesantiallergic medicinesmedicines for the treatment of gastrointestinal diseasesmedicines for the treatment of migraine and cancer; medicines for veterinary purposesantiallergic medicinesmedicine for the treatment of migraine and cancermedicines for the treatment of gastrointestinal diseases; medicines for dental purposesbacteriostats for medicinal and dental usemedicinal preparations for the mouth and as sprays
Class 35
Compilation of information into computer databasesparticularly in the field of biologybiotechnology and pharmacy; business management related to the marketing of technical and research results; business management related to managing research
Class 38
Providing access to databases
Class 42
Scientific and technological servicesscientific researchdesign and testing for new product development particularly for the development of active substancesmedicine and therapy methods; research and development for othersresearch and development for new products for othersscientific research for others; research in the field of science and technical research; laboratory services as included in this classchemical and biochemical laboratorieslaboratory research; all beforementioned services particularly in the fields of biologybiotechnology and pharmacychemicalbiochemicalbiological analysis; development of biologicalbiotechnologicalpharmaceutical analysis methods and their application for others; computer software design; technical and scientific consultancyparticularly in the fields of biologybiotechnology and pharmacy; scientific research; scientific surveysconducting biochemical and pharmaceutical surveys for scientific and medical research and analysis purposes
Class 44
Medical services; veterinary services; sanatoriums; pharmacy advice; artificial insemination services; nursing homes; in vitro fertilization services; blood bank services; aromatherapy services; phototherapy servicesproviding light therapy for treating medical conditions; photodynamic therapy servicesproviding light therapy for treating medical conditions; medical laboratory services
Publications
History of USPTO decisions and trademark events.
51 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/26/2026
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
10/04/2019
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
06/07/2019
INPC
INVALIDATION PROCESSED
06/06/2019
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
05/19/2019
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
09/19/2018
71AG
REGISTERED-SEC.71 ACCEPTED
09/19/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/06/2018
ES71
TEAS SECTION 71 RECEIVED
08/22/2018
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
09/30/2017
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
06/01/2017
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
05/26/2017
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
05/19/2017
RNWL
INTERNATIONAL REGISTRATION RENEWED
05/18/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/15/2015
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
03/20/2014
71AG
REGISTERED-SEC.71 ACCEPTED
03/20/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/19/2014
71AF
REGISTERED-SEC.71 FILED
02/25/2014
ES71
TEAS SECTION 71 RECEIVED
02/25/2014
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/29/2013
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/06/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/16/2009
FIMP
FINAL DISPOSITION PROCESSED
01/16/2009
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/30/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
09/30/2008
PUBO
PUBLISHED FOR OPPOSITION
07/15/2008
NPUB
NOTICE OF PUBLICATION
06/25/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/07/2008
ALIE
ASSIGNED TO LIE
06/07/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/07/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/13/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/13/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/13/2008
CNRT
NON-FINAL ACTION MAILED
04/22/2008
CNRT
NON-FINAL ACTION WRITTEN
04/22/2008
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/21/2008
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/21/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/21/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/21/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/21/2008
RFNT
REFUSAL PROCESSED BY IB
11/09/2007
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/19/2007
RFRR
REFUSAL PROCESSED BY MPU
10/19/2007
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/19/2007
CNRT
NON-FINAL ACTION WRITTEN
10/18/2007
DOCK
ASSIGNED TO EXAMINER
10/13/2007
DOCK
ASSIGNED TO EXAMINER
10/06/2007
NWAP
NEW APPLICATION ENTERED
10/05/2007
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/04/2007
Continuous trademark protection
Get notified about every new filing that threatens BIOFRONTERA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.